monolix Suite 2021R2 (x64)
x64 | File Size: 162 MB
Lixoft develops modeling and simulation software for advanced model-based drug development. Its products offer powerful and easy solutions for population analysis in pre-clinical, clinical trials and in treatment individualization.
Lixoft’s technologies are the result of a ten years research program in statistics and modeling, led by Inria on non-linear mixed effect models for advanced population analysis, pharmacometrics, pre-clinical and clinical trial modeling & simulation.
PKanalix is a user friendly and fast application for compartmental and non-compartmental analysis (NCA)
Very intuitive interface
PKanalix can be used via a graphical interface to easily define settings and rules, check the calculations and display the results. It can also be used via R for powerful scripting.
Straightforward NCA
PKanalix calculates NCA parameters with industry-standard methods, and automatically generates a full set of plots to visualize the data, the distributions of calculated parameters and correlations with covariates.
Reliable and clear results
All results are available as tables and summaries, and as interactive plots for a fast and intuitive interpretation. All settings are saved in the project for reproducible results, and the integrated validation suite ensures correct installation and calculation.
Compartmental analysis
Calculation of the parameters in the Compartmental Analysis framework is also proposed with a large library of PK models. In addition, it includes a direct link toward population modeling using Monolix.
Monolix, the best tool for Model Based Drug Development
Monolix is the most advanced and simple solution for non-linear mixed effects modeling (NLME) for pharmacometrics. It is based on the SAEM algorithm and provides robust, global convergence even for complex PK/PD models. Monolix is used for...
Read more
Continue reading...